UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042032 |
|---|---|
| Receipt number | R000047968 |
| Scientific Title | Evaluation of concentration and relaxation using scents for professional soccer players. |
| Date of disclosure of the study information | 2020/10/07 |
| Last modified on | 2020/10/07 09:53:34 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of concentration and relaxation using scents for professional soccer players.
Acronym
Evaluation of concentration and relaxation using scents for professional soccer players.
Scientific Title
Evaluation of concentration and relaxation using scents for professional soccer players.
Scientific Title:Acronym
Evaluation of concentration and relaxation using scents for professional soccer players.
Region
| Japan |
Condition
Condition
Adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To verify the influence to concentration and relaxation when smelling aroma.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Heart beat
Body temperature
Body motion
Acceleration
The result of concentration tests
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
Do concentration test with green fragrance in the air wearing heart rate monitor.
Interventions/Control_2
Do concentration test without any fragrance in the air wearing heart rate monitor.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 19 | years-old | <= |
Age-upper limit
| 50 | years-old | > |
Gender
Male
Key inclusion criteria
1)Professional soccer player of Iwaki FC.
2)Who shows understanding of this study procedures and agreement with participating the study by written informed consent prior to the study.
3)Who can fill in the questionnaires.
4)Healthy individuals
Key exclusion criteria
1)Who has/may have allergy.
2)Others who have been determined ineligible by principal investigator or sub-investigator.
Target sample size
24
Research contact person
Name of lead principal investigator
| 1st name | AKARI |
| Middle name | |
| Last name | HOSHI |
Organization
ROHTO Pharmaceutical Co., Ltd.
Division name
Business Strategy Office
Zip code
1050014
Address
ROHTO Tokyo Bldg F5. 1-7-5, Shiba, Minato-ku, Tokyo
TEL
080-9931-8609
hoshi@rohto.co.jp
Public contact
Name of contact person
| 1st name | AMI |
| Middle name | |
| Last name | MIURA |
Organization
KANSEI Projects Committee
Division name
Project Coordinator
Zip code
1540011
Address
#6 THE FORUM setagaya 5-15-15 Kamiuma Setagaya, Tokyo
TEL
080-5693-4413
Homepage URL
miura@kanseiproject.com
Sponsor or person
Institute
ROHTO Pharmaceutical Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
ROHTO Pharmaceutical Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Clinical Research Ethics Review Committee
Address
1-8-1 Tatsumi nishi Ikuno Osaka, Osaka
Tel
0774-71-8820
takeuchiy@rohto.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 10 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
24
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 09 | Month | 23 | Day |
Date of IRB
| 2020 | Year | 09 | Month | 23 | Day |
Anticipated trial start date
| 2020 | Year | 10 | Month | 08 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 10 | Month | 07 | Day |
Last modified on
| 2020 | Year | 10 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047968
